Pfizer announces IES analysis of Aromasin in breast cancer recurrence - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Pfizer announces IES analysis of Aromasin in breast cancer recurrence

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

12-11-2009, 03:14 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	Pfizer announces IES analysis of Aromasin in breast cancer recurrence Pfizer today announced results from an exploratory analysis of the Intergroup Exemestane Study (IES) at a median follow-up of 91 months in estrogen-receptor positive (ER+) or estrogen-receptor unknown (ER-unknown) women that looked at breast cancer free survival (BCFS) and censored deaths that occurred prior to breast cancer relapse. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 11:11 AM.

free webpage hit counter